189 related articles for article (PubMed ID: 11602401)
1. [Skin necrosis induced by heparin: apropos of 2 cases].
Andolfatto S; Latger-Cannard V; Maistre ED; Briquel ME; André E; Montange F; Reichert S; Lecompte T
Ann Biol Clin (Paris); 2001; 59(5):651-4. PubMed ID: 11602401
[No Abstract] [Full Text] [Related]
2. Danaparoid thromboprophylaxis in pregnant women with heparin-induced thrombocytopenia.
Woo YL; Allard S; Cohen H; Letsky E; de Swiet M
BJOG; 2002 Apr; 109(4):466-8. PubMed ID: 12013171
[No Abstract] [Full Text] [Related]
3. [Clinical experiences with Danaparoid sodium. Measures to be taken in heparin-induced thrombocytopenia].
Anaesthesist; 1998 Nov; 47(11 Suppl Massnahmen):1-4. PubMed ID: 9884734
[No Abstract] [Full Text] [Related]
4. [Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia].
Chirurg; 1998 Nov; 69(11 Suppl Massnahme):1-4. PubMed ID: 9853175
[No Abstract] [Full Text] [Related]
5. [Successful lysis therapy of inferior vena cava and iliofemoral venous thrombosis in heparin-induced thrombocytopenia type II].
Fischer KG
Dtsch Med Wochenschr; 1999 Jan; 124(1-2):32-3. PubMed ID: 9951458
[No Abstract] [Full Text] [Related]
6. [Heparin-associated platelet aggregation syndrome with skin necrosis during hemodialysis].
Bredlich RO; Stracke S; Gall H; Proebstle TM
Dtsch Med Wochenschr; 1997 Mar; 122(11):328-32. PubMed ID: 9102281
[TBL] [Abstract][Full Text] [Related]
7. Use of danaparoid during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia.
Olin DA; Urdaneta F; Lobato EB
J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):707-9. PubMed ID: 11139115
[No Abstract] [Full Text] [Related]
8. [Heparin-induced thrombocytopenia].
Christoffersen C; Lethagen S; Gøtze JP
Ugeskr Laeger; 2009 Feb; 171(8):612-5. PubMed ID: 19284907
[TBL] [Abstract][Full Text] [Related]
9. Heparin-induced thrombocytopaenia complicated by arterial and venous thrombosis: report of 2 cases successfully treated by a danaparoid sodium.
Darling K; Jaumotte C; Saussoy P; Zech F; Lavenne E; Hainaut P
Acta Clin Belg; 2000; 55(3):176-81. PubMed ID: 10981327
[TBL] [Abstract][Full Text] [Related]
10. [Thrombopenia induced by heparin: treatment with Org 10172. Tolerability and efficacy].
Tardy-Poncet B; Reynaud J; Tardy B; Mahul P; Mismetti P; Beraud AM; Rebaud MA; Bayon M; Guyotat D
Presse Med; 1996 May 4-11; 25(16):751-5. PubMed ID: 8692750
[TBL] [Abstract][Full Text] [Related]
11. Persistent heparin-induced thrombocytopenia: danaparoid cross-reactivity or delayed-onset heparin-induced thrombocytopenia? A case report.
Horlait G; Minet V; Mullier F; Michaux I
Blood Coagul Fibrinolysis; 2017 Mar; 28(2):193-197. PubMed ID: 27100305
[TBL] [Abstract][Full Text] [Related]
12. Treatment of heparin-induced thrombocytopenia.
Peters FP
J Thorac Cardiovasc Surg; 1997 Sep; 114(3):517-8. PubMed ID: 9305220
[No Abstract] [Full Text] [Related]
13. Delayed-type hypersensitivity to subcutaneous heparin with tolerance of i.v. administration.
Liew G; Campbell C; Thursby P
ANZ J Surg; 2004 Nov; 74(11):1020-1. PubMed ID: 15550103
[No Abstract] [Full Text] [Related]
14. Danaparoid sodium (Orgaran) in four children with heparin-induced thrombocytopenia type II.
Zöhrer' B; Zenz W; Rettenbacher A; Covi P; Kurnik K; Kroll H; Grubbauer HM; Muntean W
Acta Paediatr; 2001 Jul; 90(7):765-71. PubMed ID: 11519979
[TBL] [Abstract][Full Text] [Related]
15. Danaparoid sodium.
Acostamadiedo JM; Iyer UG; Owen J
Expert Opin Pharmacother; 2000 May; 1(4):803-14. PubMed ID: 11249517
[TBL] [Abstract][Full Text] [Related]
16. The use of low dose Orgaran in heparin-induced thrombocytopenia associated with in vitro platelet aggregation at higher Orgaran concentrations.
Hill GR; Hickton C; Henderson S; Patton WN
Clin Lab Haematol; 1997 Jun; 19(2):155-7. PubMed ID: 9218159
[TBL] [Abstract][Full Text] [Related]
17. Portal vein thrombosis treated using danaparoid sodium and antithrombin III.
Uchiyama T; Hirokazu T; Hosono K; Endo H; Akiyama T; Yoneda K; Inamori M; Abe Y; Kubota K; Saito S; Nakajima A
Hepatogastroenterology; 2010; 57(97):52-3. PubMed ID: 20422871
[TBL] [Abstract][Full Text] [Related]
18. Successful thrombolysis of right atrial and ventricle thrombi encircling a temporary pacemaker lead in a patient with heparin-induced thrombocytopenia type II.
Janssens U; Breithardt OA; Greinacher A
Pacing Clin Electrophysiol; 1999 Apr; 22(4 Pt 1):678-81. PubMed ID: 10234725
[TBL] [Abstract][Full Text] [Related]
19. [Current treatment concepts in heparin-induced thrombocytopenia].
Ranze O; Greinacher A
Dtsch Med Wochenschr; 1999 Jul; 124(28-29):865-73. PubMed ID: 10432950
[No Abstract] [Full Text] [Related]
20. Heparin-induced thrombocytopenia type II: successful use of Orgaran (ORG 10172) in intensive care patients.
Burkhard-Meier U; Söhngen D; Schultheiss HP; Greinacher A; Schwartzkopff B; Vogt M; Heyll A; Schneider W
Intensive Care Med; 1995 Jun; 21(6):542-3. PubMed ID: 7560499
[No Abstract] [Full Text] [Related]
[Next] [New Search]
